VERANasdaqPharmaceutical PreparationsFiscal year ends December 31
Vera Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$28.92+1.04 (+3.73%)
Close on Oct 19, 2026
- Market cap
- $2.08B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Vera Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 15, 2026 | Sep 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2026 | Jul 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 21, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 9, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 25, 2025 | Nov 26, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 14, 2025 | Apr 3, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 26, 2024 | Oct 28, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2024 | Oct 2, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jul 2, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 7, 2024 | Jun 12, 2024 | SEC EDGAR |